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Abstract: Peroxisome proliferator activated receptor γ co-activator 1α (PGC-1α) is a regulator of
mitochondrial oxidative metabolism and reactive oxygen species (ROS) homeostasis
that is known to be inactivated in diabetic subjects. This study aimed to investigate the
contribution of PGC-1α inactivation to the development of oxygen-induced retinopathy.
We analyzed retinal vascular development in PGC-1α-/- mice. Retinal vasculature of
PGC-1α-/- mice showed reduced pericyte coverage, a de-structured vascular plexus,
and low perfusion. Exposure of PGC-1α-/- mice to hyperoxia during retinal vascular
development exacerbated these vascular abnormalities, with extensive retinal
hemorrhaging and highly unstructured areas as compared with wild-type mice.
Structural analysis demonstrated a reduction of membrane bound VE-cadherin, which
was suggestive of defective inter-cellular junctions. Interestingly, PGC-1α-/- retinas
showed a constitutive activation of the VEGF-A signaling pathway. This phenotype
could be partially reversed by antioxidant administration, indicating that elevated
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production of ROS in the absence of PGC-1α could be a relevant factor in the
alteration of the VEGF-A signaling pathway. Collectively, our findings suggest that
PGC-1α control of ROS homeostasis plays an important role in the regulation of de
novo angiogenesis, and is required for vascular stability.
Response to Reviewers: Maria Monsalve, PhD
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Madrid, 22nd of December, 2015
Dear Editor,
We respectfully submit the revised version of the manuscript, entitled “Oxidative stress
induces loss of pericyte coverage and vascular instability in PGC-1α deficient mice”
(Manuscript reference: AGEN-D-15-00133) which we submit for consideration as an
article in Angiogenesis.
In this study we show that retinas from PGC-1α knockout mice show reduced pericyte
coverage together with a more disorganized structure and a poor perfusion. This
phenotype is exacerbated following an oxygen-induced retinopathy procedure, and
PGC-1α-/- mice exhibit extensive hemorrhaging. Molecular analysis showed normal
levels of VEGF-A, and a constitutively active VEGF-A signaling pathway, whose
activity was paradoxically not induced by OIR. We considered that the observed
phenotype could be due to the excessive ROS levels, previously reported to be a
hallmark of PGC-1α inactivation. Indeed, antioxidant treatment partially corrected the
phenotype, indicating that ROS-dependent alterations in VEGF-A signaling are likely to
be important in the vascular instability associated with the absence of PGC-1α.
We believe our results are of interest to the readership of Angiogenesis since they
suggest that microvascular anomalies that are characteristic of metabolic dysfunctions,
may be related to low levels of PGC-1α activity in the vascular endothelium. Further,
our findings provide new mechanistic insights into vascular biology and disease,
because in patients with metabolic disease, reduced PGC-1α activity is likely to cause
a ROS-dependent inactivation of key VEGF-A signaling pathway nodes, and this
inactivation can be relevant in the development of microvascular anomalies.
Below we provide a detailed account of all the changes made to the manuscript in
response to the reviewers’ comments. We believe this new version answers the
reviewer’s criticisms, and that the scientific interest of the work has been increased.
I hope you will find our manuscript of interest.
Sincerely yours,
María Monsalve
Maria Monsalve, PhD
Instituto de Investigaciones Biomédicas Alberto Sols
Dept. Metabolism and Cell Signalling
Arturo Duperier, 4
28029-Madrid (Spain)
Phone: 915854471
Fax: 915854401
e-mail: mpmonsalve@iib.uam.es
Point by point answer to reviewers:
Reviewer 1:
1.The language can be tightened up in several places: examples are in abstract line 2:
"—has been show to be—" should be "has been shown to be—" and in introduction,
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and page 5, paragraph 2, line 2 should be "---mitochondrial function and ROS—" Also
in results page 11, paragraph 2, "—matrigel plugs where used—" should be "—plugs
were used---"
Answer. The text has been revised and corrected as indicated.
2.Abstract: Line 4: It is more appropriate to refer this study as aiming to study the
development of oxygen-induced retinopathy. Although they share some features, the
model they used is oxygen-induced and not diabetes induced retinopathy.
Answer. The sentence has been corrected and now reads: “This study aimed to
investigate the contribution of PGC-1α inactivation to the development of oxygen-
induced retinopathy.”
3.The conclusion at the end of abstract also refers to the role of mitochondrial ROS in
the vascular abnormalities in PGC-1a deficient mice; this is based on partial reversal
by an anti-oxidant. This conclusion is overstated. It is not clear that EUK-189
specifically scavenges mitochondrial ROS. It is more appropriate to say a role for ROS
is possible based on partial reversal by EUK-189
Answer. The sentence has been corrected and now reads: “This phenotype could be
partially reversed by antioxidant administration, indicating that elevated production of
ROS in the absence of PGC-1α could be a relevant factor in the alteration of the
VEGF-A signaling pathway.”
4.Methods section, it is important to mention what conc. of O2 and for how many days
the pups were exposed for the retinopathy model in mice. This is particularly important
to evaluate the effects of EUK compound and how its timing of administration
corresponds to O2 exposure.
Answer. The required details have now been included in the Methods section. The text
now reads: “In brief, p7 pups where transferred with their mothers to a hyperoxia
chamber set at 70% O2 where they stayed for 5 days, and then returned to normoxic
conditions. P17 pups were sacrificed. EUK-189 (30 mg/kg in PBS) was administered
daily by intraperitoneal injection from day 4 to day 7 and from day 12 to day 17.”
5.The specific anti-oxidant properties of EUK-189 need to be mentioned- does it
scavenge superoxide or H2O2? If so it is limited to cytosolic compartment or does it get
targeted to mitochondria?
Answer. The required details and references have now been included in the Methods
section. The following sentence has been included in the text: “EUK-189 is a salen-
manganese complex and superoxide dismutase/catalase mimetic that has been shown
to be effective as antioxidant in vivo and in the inactivation of mitochondrial ROS [12].”
6.The manuscript refers to increase in mitochondrial ROS as possible mechanism
involved in PGC-1α deficient mice; however the study did not attempt to measure even
qualitatively differences in mitochondrial ROS between WT and PGC-1α deficient mice
Answer. Elevated ROS in PGC-1α-/- cells (vascular endothelium, MEFs, primary
hepatocytes) have been reported (Y. Olmos et al., JBC, 2009; S. Borniquel et al., MCB,
2010; C. Sánchez-Ramos et al., ARS, 2011) elevated levels of ROS induced
modifications (protein carbonylation) in PGC-1α-/- mice have been reported (F. Derbré
et al., AGE, 2011).
Mouse Lung Endothelial Cells (MLEC)
S. Borniquel et al., MCB, 2010
We have now analyzed the level of oxidative protein modification in wild-type and
PGC-1α-/- MLEC, the results are shown in Supp. Fig. 11.
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7.The loss of mitochondria and oxidative capacity has been speculated in the PGC-1α
deficient mice as potential mechanisms involved in the disorganized microvasculature.
However, it is unclear whether mitochondrial biogenesis is disrupted in the vessels. It is
possible that loss of PGC-1α leads to defective angiogenesis through other
mechanisms.
Answer. We have now evaluated mitochondrial density and cellular distribution (a
hallmark of mitochondrial activity) in wild-type and PGC-1α-/- primary endothelial cells.
We have found a reduced mitochondrial density and a more pronounced perinuclear
distribution in PGC-1α-/- cells, supporting the hypothesis of a disrupted mitochondrial
biogenesis and reduced mitochondrial activity. Results are shown in Supp. Fig. 10.
8.Loss of pericyte coverage is an important observation. The potential mechanisms are
not addressed further in the study protocol or in the discussion.
Answer. We have now discussed this important issue in the Discussion section. The
added text reads: “It is generally acknowledged that pericyte coverage is essential for
vessel stabilization and there are several pathways involved in the intimate crosstalk
between the vascular endothelial cell and the pericyte. As a result, endothelial
dysfunction generally results in pericyte loss and vice versa. Among the pathways
involved the TGF-β, and the angiotensin system, have been extensively characterized.
Importantly, the VEGFR2 has also been shown to be involved in this regulatory
process. In light of the previous evidence showing that loss of PGC-1α results in
enhanced cell migration and of the present results suggesting that loss of PGC-1α
alters the VEGFR2 signaling pathway, it is possible that this alteration may be
responsible for the observed loss in pericyte coverage, although alternative scenarios
are also possible. Importantly, recent reports suggest a connection between the TGF-β
pathway and PGC-1α.”
9.Results: Figure 1, Panel B summary graph for VCadherin shows similar fractions of
membrane bound and cytosolic staining, however in the results section, authors state
that VCadherin staining is more cytosolic and less membrane bound in PGC-1a -/-
mice. This requires clarification.
Answer. The text read: “Although VE-cadherin staining was reduced in PGC-1α-/-
animals, normal membrane distribution was preserved”. It meant to explain that the
total signal (protein amount) for VE-cadherin was reduced in PGC-1α-/- animals but
that the distribution of the signal was not different in WT versus KO animals, and that is
what is shown in the graph. To avoid misunderstandings we have changed the text that
now reads: “VE-cadherin staining showed that its normal membrane distribution was
preserved in PGC-1α-/- animals”.
10.Figure 1, Panel D, representative blot appears to show higher intensity band for
VEGFA in the -/- mice, however, the summary graph shows no difference. Considering
the HIF-1 activation in -/- mice, one would expect higher VEGFA. This needs
clarification.
Answer. The blots show exactly what we got, the protein levels of VEGF-A where if
anything higher in PGC-1α-/- animals, but the differences did not reach statistical
significance. That VEGF-A levels are not significantly elevated may be due to the
described induction of VEGF-A expression by PGC-1α, in fact VEGF-A mRNA levels
are reduced in the PGC-1α-/- mice. This information is included in the text and shown
in Supp. Fig. 2.
11.The legend for Figure 2 has transposed description of panel D for panel B. This
makes the figure confusing to interpret. Also more detailed description of findings is
needed for this complex figure. Panel D alone has multiple photo-micrographs that
need explanation for the reader
Answer. The transposition has been fixed. We have also expanded the discription of
Figure 2D, that now reads: Fig 2D contrasts a typical branching wild-type vessel on the
top panel, with examples of the anomalies that we could find in PGC-1α-/- mice, from
top to bottom we can see, the irregularity of the lumen in a lengthwise section of a
vessel, with a constriction point, a cross section of a collapsed vessel, and a dilated
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irregular vessel in cross section.
12.Figure 3 also has extensive data with scant description of the panels and
interpretation of data. The figure can be split into 2 and better explanation given to be
able to assess the changes with O2 exposure.
Answer. We have now expanded the description and interpretation of Figure 3 as
suggested.
13.The authors discuss the possibility that ischemia leads to loss of PGC-1a, which
then leads to activation of HIF-1a signaling. This possibility can be tested by blotting for
PGC-1a in the retina in the WT mice in control and OIR stress. Along the same lines, a
blot to show that PGC-1a is indeed lost in the -/- animals is needed to verify the KO
Answer. We have studied the regulation of PGC-1α by hypoxia in the context of
another study that we are about to submit for publication (C. Sanchez et al.). We
confidentially include here  (in a file uploaded separatelly) some of the data that shows
that PGC-1α is downregulated by hypoxia (1% O2) when cells are cultured in vitro at
physiological O2 concentrations (3% O2), and induced by reoxigenation.
We have included a western blot for PGC-1α in Supp. Fig. 11.
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Abstract 
 
Peroxisome proliferator activated receptor  co-activator 1 (PGC-1) is a regulator of mitochondrial 
oxidative metabolism and reactive oxygen species (ROS) homeostasis that is known to be inactivated 
in diabetic subjects. This study aimed to investigate the contribution of PGC-1 inactivation to the 
development of oxygen-induced retinopathy. We analyzed retinal vascular development in PGC-1-/- 
mice. Retinal vasculature of PGC-1-/- mice showed reduced pericyte coverage, a de-structured 
vascular plexus, and low perfusion. Exposure of PGC-1-/- mice to hyperoxia during retinal vascular 
development exacerbated these vascular abnormalities, with extensive retinal hemorrhaging and 
highly unstructured areas as compared with wild-type mice. Structural analysis demonstrated a 
reduction of membrane bound VE-cadherin, which was suggestive of defective inter-cellular 
junctions. Interestingly, PGC-1-/- retinas showed a constitutive activation of the VEGF-A signaling 
pathway. This phenotype could be partially reversed by antioxidant administration, indicating that 
elevated production of ROS in the absence of PGC-1 could be a relevant factor in the alteration of 
the VEGF-A signaling pathway. Collectively, our findings suggest that PGC-1 control of ROS 
homeostasis plays an important role in the regulation of de novo angiogenesis, and is required for 
vascular stability. 
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List of Abbreviations 
Protein kinase B = AKT. 
Cadherin 5 = cdh-5. 
4 ',6-diamino-2-fenilindol = DAPI. 
Delta like-1 = dll1. 
Delta like-4 = dll4. 
Eukarion-189 = EUK-189. 
Hairy and enhancer of split-1 = hes1. 
Hairy/enhancer-of-split related with YRPW motif protein 1 = hey1. 
4-Hydroxynonenal = HNE 
Hypoxia inducible factor-1α = HIF-1α. 
Immunofluorescence = IF. 
Isolectin B4 = IsoB4. 
Neuron-glial antigen 2 = NG2. 
NOTCH intracellular domain = NICD. 
Phosphorylated = P-. 
Peroxisome proliferator activated receptor γ-coactivator 1α = PGC-1α. 
Postnatal day 17 (P17). 
Reactive oxygen species = ROS. 
SMA = Smooth muscle actin. 
Vascular endothelial growth factor-A = VEGF-A. 
Vascular endothelial cadherin = VE-Cadherin. 
Vascular endothelial growth factor receptor 2 = flk1 (gene), VEGFR2 (protein). 
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Introduction 
 
The importance of protecting the body from the most common metabolic disorders including obesity 
and type 1 and type 2 diabetes cannot be overstated, and their prevalence continues to increase yearly 
and worldwide. Dysfunctions of the human vascular tree are the major sources of morbidity and 
mortality. Generally, the damaging effects can be separated into macrovascular (coronary artery 
disease, peripheral arterial disease, and stroke) and microvascular (nephropathy, neuropathy, and 
retinopathy) injury [1]. Diabetic retinopathy is one of the most common microvascular complications 
of diabetes and is a leading cause of ∼10,000 new cases of blindness every year in the USA alone [2]. 
 
Metabolic disorders are characterized fundamentally by a poor use of mitochondria as a source of ATP 
and a preponderance of anaerobic glycolysis [3,4]. This decrease in mitochondrial function is 
mediated principally by the down-regulation and functional inactivation of the transcriptional 
coactivator peroxisome proliferator-activated receptor gamma coactivator-1-alpha (PGC-1) [5,6], a 
master regulator of genes involved in oxidative metabolism. Loss of PGC-1 activity results in an 
increase of mitochondrial-derived reactive oxygen species (ROS) [7], and elevated ROS levels 
(oxidative stress) have been found in the majority of vascular complications associated with metabolic 
disorders. 
 
Our previous results showed that PGC-1 was present in vascular endothelial cells (ECs), and its 
levels were reduced by hyperglycemia. Furthermore, PGC-1 could coordinate EC oxidative 
metabolism and antioxidant capacity [8], suggesting that PGC-1 could play a key role in the 
physiology of the vascular endothelium. Additional studies from our laboratory showed that, at least in 
vitro, PGC-1 was a negative regulator of EC migration indicating that PGC-1 activity could be 
important for the control of vascular stability and angiogenesis. Accordingly, activation of PI3K-AKT 
signaling in response to angiogenesis mediators resulted in the down-regulation of PGC-1, leading to 
GARCÍA-QUINTANS ET AL. 
5  
increased mitochondrial ROS levels and enhanced EC migration [9]. ROS are acknowledged as 
important signaling mediators regulating cell proliferation and migration [10]. 
 
In this study we aimed to characterize the role of PGC-1 as a regulator of mitochondrial function and 
ROS in the control of angiogenesis, and to evaluate its possible contribution to vascular diseases, 
particularly diabetic retinopathy.  
 
We found that the retinal vasculature in PGC-1-/- animals exhibited characteristics of an unstable 
phenotype that was exacerbated upon exposure to an oxygen-induced retinopathy (OIR) protocol. 
Crucially, this phenotype could be partially rescued by antioxidant treatment, suggesting that 
excessive ROS production likely plays a role in microvascular instability. 
 
Materials & Methods 
 
Animal handling. C57BL6 PGC-1+/+ and PGC-1-/- were used. All animal experiments were 
performed in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision 
Research. Animal protocols were approved by the Institutional Animal Care and Use Committee of 
the CNIC and the CSIC. All procedures conformed to the Declaration of Helsinki and the NIH 
guidelines for animal care and use (NIH publication No. 85-23).  
 
Oxygen induced retinopathy (OIR). Ischemic retinopathy was generated according to an established 
OIR protocol [11]. In brief, p7 pups where transferred with their mothers to a hyperoxia chamber set at 
70% O2 where they stayed for 5 days, and then returned to normoxic conditions. P17 pups were 
sacrificed. EUK-189 (30 mg/kg in PBS) was administered daily by intraperitoneal injection from day 
4 to day 7 and from day 12 to day 17. EUK-189 is a salen-manganese complex and superoxide 
dismutase/catalase mimetic that has been shown to be effective as antioxidant in vivo and in the 
inactivation of mitochondrial ROS [12]. 
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Retina isolation. Postnatal day 17 (P17) pups were euthanized in a CO2 chamber. Eyes were 
enucleated and fixed in 4% paraformaldehyde (PFA) in PBS at 4ºC for 48 h 
 
Whole mounts staining. Retinas were postfixed for 1 h in fixative solution, blocked and permeabilized 
in PBS containing 1% bovine serum albumin (BSA) and 0.5% Triton-X100, for 2.5 h at RT. The 
staining solution was PBS pH 6.8 with 0.1 mM CaCl, 0.1 mM MgCl and 0.1 mM MnCl and the 
antibodies used were: FITC-conjugated anti-Griffonia simplicifolia Isolectin B4 from Sigma-Aldrich 
(L2895), anti-NG2 from Millipore (AB5320) and Cy3-conjugated anti-smooth muscle -actin from 
Sigma-Aldrich (C6198). Staining was performed for 48 h at 4oC. For VE-cadherin staining (550548, 
anti-CD144, BD Pharmingen), the retinas were first blocked and permeabilized with PBS containing 
5% FBS and 0.3% Triton-X100, and then washed for 1.5 h in PBS. Incubations with fluorescent 
tagged secondary antibodies were performed for 2 h at RT, and included Alexa-fluor 647 chicken anti-
rabbit (Invitrogen) and Alexa-fluor 488 chicken anti-rat (Invitrogen). DAPI (1:1000) (Invitrogen) was 
used for nuclear visualization. Retinal images were acquired with a Zeiss LSM 700 or LSM 710. 
Unless otherwise indicated, images shown are maximal projections of z-stacks covering the whole 
retinal section. 
 
Eye cross sections. Eyes were enucleated, fixed (70% ethanol, 10% formalin and 5% acetic acid) for 
48 h and embedded in paraffin. Sections of 4 m were stained with hematoxylin and eosin (H&E). 
Images were acquired with a Nikon 90i microscope. 
 
Vascular perfusion and leakage. Mice were injected via tail vein or retro-orbitaly with 100 l FITC-
dextran (FD2000S; Sigma-Aldrich) at a concentration of 40 mg/ml in PBS. The animals were 
sacrificed 5 min later. Images of retinal flatmounts were obtained by confocal microscopy. Retinal 
segments were merged to generate a whole retinal image using Nikon A1R software. 
 
GARCÍA-QUINTANS ET AL. 
7  
Matrigel angiogenesis assay. Matrigel and growth factor reduced (GFR) Matrigel (10 mg/ml) were 
mixed with 25 U/ml heparin (Sigma-Aldrich). VEGF-A (8 g/ml) was added to GFR Matrigel as 
indicated. Three hundred microliters of the mixture was injected subcutaneously. Implants were 
harvested after 2 weeks and fixed in formalin for 12 h. Half of the sample was embedded in OCT and 
frozen. The other half was embedded in paraffin. Samples were analyzed by immunofluorescence 
using the previously indicated antibodies and an anti-CD31 antibody to assess blood vessel formation 
and vascular patterns (557355, BD Pharmingen).  
 
Cell culture. Mouse Lung Endothelial Cells (MLECs) were obtained and cultured as described [9]. 
Wild-type and PGC-1-/- MLEC were cultured in round glass coverslips, fixed with PFA 4%, 
permeabilized and blocked with 10% FBS/0.3% Triton X-100 and were incubated with an 
antibody against Tomm22 (HPA003037, Sigma-Aldrich). Cells were counterstained with 
DAPI (Molecular Probes) and mounted with ProLong (Molecular Probes). Photographs were 
taken with a spectral confocal microscope LSM710 (Zeiss) and analyzed using ImageJ 
software. Whole cell extracts were analyzed by western blotting using antibodies directed 
against PGC-1 (ST1202, Millipore) and 4-Hydroxynonenal (HNE) (HNE11, Alpha 
Diagnostic Int.) 
 
Protein extraction and western blotting was performed as previously described [13]. Specific 
antibodies used were: HIF-1 (610958, BD Transduction Laboratories), VEGF-A, (VG-1, Santa 
Cruz), VEGF-R2 (55B11, 1:1000), P-VEGFR2 ( 2471, 1:1000), NICD (4147, 1:1000), AKT 
(2920) and phosphorylated AKT-Ser473 (4060) (1:2000), all from Cell Signaling Technology, and -
actin (A 5441, Sigma).  
 
RNA isolation and qRT-PCR was performed as previously described [13].  
Specific oligonucleotides were: 
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vegf-a:  
Forward: 5´-GAAGTCCCATGAAGTGATCAAGT-3´ 
Reverse: 5´-CTTTGGTCTGCATTCACATCT-3´ 
flk1:  
Forward: 5´-CTCTCCACCTTCAAAGTCTCAT-3´ 
Reverse: 5´-GGCTTTGTGTGAACTCGGACAA-3´ 
dll 4:  
Forward: 5´-ACCAACTCCTTCGTCGTCAG-3´ 
Reverse: -5´-AGGGTGTCATTTTGCTCGTCT-3´ 
notch 1:  
Forward: 5´-GGTGTCTTCCAGATCCTGCT-3´ 
Reverse: 5´-AGTCTCCTCCTTGTTGTTCTG-3´ 
dll 1:  
Forward: 5´-CAATGGAGGACGATGTTCAG-3´ 
Reverse: 5´-CAGGTAAGAGTTGCCGAGGT-3´ 
hes 1:  
Forward: 5´-CTGCTACCCCAGCCAGTGT-3´ 
Reverse: 5´-CGGAGGTGCTTCACAGTCATT-3´ 
hey 1:  
Forward: 5´-GAAAAGACGGAGAGGCATCAT-3´ 
Reverse: 5´-GTGCGCGTCAAAATAACCTT-3´ 
jagged 1:  
Forward: 5´-CAGTGCCTCTGTGAGACCAA-3´ 
Reverse: 5´-GTTATGGCAGGGGTCAGAGA-3´ 
cdh 5 (VE-cadherin):  
Forward: 5´-CCAAATCGTGAAAGGAAATGA-3´ 
Reverse: 5´-CAGGCACCGAAAATGTGTATG-3´ 
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Image analysis. ImageJ software was used to analyze western blots signals and for global 
determination of areas in immunofluorescent images, vascular shape analysis of Matrigel plugs and 
membrane/cytosol ratios of VE-cadherin. Angio-Tool was used for analysis of retinal vascular plexus. 
H&E images were reviewed manually. 
 
Statistics. Data are expressed as means ±SD. Statistical significance was evaluated by analysis of 
variance or a nonparametric test, as appropriate. Values were considered statistically significant at p < 
0.05; n= 3 independent experiments, where n= 3-5 animals per group in each independent experiment. 
 
Results 
 
To assess the functional consequences of PGC-1 deficiency, we analyzed the retinal vasculature of 
PGC-1-/- pups. The retinal vasculature develops postnatally in the mouse and at P17 angiogenesis 
initiating at the center of the retina is expected to have reached the retinal edge. No gross structural 
differences could be detected in the vascular network of retinas from P17 PGC-1-/- mice compared 
with wild-type littermates as visualized by FITC-isolectin B4 immunohistochemistry, indicating a lack 
of major developmental problems (Fig. 1A, top panel). Furthermore, no reduction in the density of the 
vascular plexus was detected (Fig. 1A, top panel). We analyzed pericyte coverage in the retina by 
immunohistochemistry using an anti-NG2 antibody that labels pericytes in the micro- and macro-
vasculature, and an anti-SMA antibody that labels smooth muscle cells of large blood vessels. No 
differences were detected in SMA staining between retinas from PGC-1-/- and PGC-1+/+ mice (Fig. 
1A, top panel). However, pericyte coverage was markedly reduced in PGC-1-/- retinas stained with 
NG2 and this reduction was more dramatic in the center of the retina than on the retinal edge where 
active angiogenesis was still ongoing (Fig. 1A, top panel). This interesting finding suggested that 
pericytes were initially recruited during the angiogenesis process and then lost. To discern the 
functional consequences of reduced pericyte coverage, we examined the microvascular structure. 
Retinas of PGC-1-/- mice had substantial disorganization of the microvasculature, with many ghost-
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like blood vessels unlikely to be perfused (Fig. 1A, mid panel). Consistently, average lacunarity in the 
primary plexus, but not in the inner plexus, was significantly reduced in PGC-1-/- retinas. Moreover, 
junction density was increased whereas average vessel length was not significantly altered (Fig. 1A, 
mid panel, and Online Supp. Fig. 1).  
 
As the in vitro characterization of PGC-1-/- ECs suggested a greater propensity to form tip cells, we 
examined retinal tip cell formation in PGC-1-/- retinas. As expected, tip cells were found only in the 
retinal edge in wild-type mice indicating active angiogenesis, with filopodia decorating only the tips of 
elongated cells (Fig. 1A, bottom panel). In contrast, PGC-1-/- retinas contained tip cells in the middle 
regions of the retina and on phalanx cells in the middle of a vessel, and with large numbers of 
filopodia close to the cell body (Fig. 1A, bottom panel). This phenotype, which is characteristic of 
excessive tip activity, is typically associated with dense vascular plexus and within this context, could 
be related to the low stability of the blood vessels. 
 
Because poor formation of intercellular junctions can result in an unstable microvasculature, we 
examined endothelial intercellular junction interactions by immunostaining for VE-cadherin. 
Nevertheless, VE-cadherin staining showed that its normal membrane distribution was preserved in 
PGC-1-/- animals (Fig. 1B, top panel).  
 
Examination of retinal cross-sections stained with H&E revealed a normal retinal structure in PGC-1-
/- mice, although a slight disorganization of the ganglion cell layer could be observed with loss of 
epithelial-like structure that could be related to poor visual function (Fig. 1B, bottom panel). The 
origin of these differences was not investigated further. 
 
To determine the impact of the reduced vascular stability on general vascular perfusion, we analyzed 
retinal perfusion using retro-orbitaly injected FITC-dextran. As expected, a marked and general 
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reduction in the perfusion in PGC-1-/- mice was detected, with a significant reduction in both the 
mean fluorescence intensity and the detectable area covered by vascular structures (Fig. 1C). 
 
To determine whether the low vascular stability of PGC-1-/- retinas might be due to an alteration in 
VEGF-A levels or activity of its downstream effectors, we monitored the expression of VEGF-A 
together with the activity/phosphorylation of its main angiogenesis receptor, VEGFR-2, and its main 
effectors, AKT and NICD. Levels of VEGF-A in PGC-1-/- retinas were comparable with retinas from 
control animals. In contrast, increased levels of total and phosphorylated VEGFR2, phosphorylated 
AKT, and of the active form of NOTCH1, NICD were detected (Fig. 1D). This result was unexpected, 
since PGC-1 is known to induce the expression of VEGF-A [14]. We therefore measured vegf-a 
mRNA levels. Consistent with previous reports [15,16], we detected lower levels in PGC-1-/- mice 
(Online Supp. Fig. 2). We also analyzed flk1 (VEGFR2) and cdh5 (VE-cadherin) mRNA levels. 
Although cdh5 levels were on average somewhat lower in PGC-1-/- mice, no significant differences 
were detected relative to wild-type mice. These findings suggested that post-transcriptional regulation 
could be responsible for the observed differences in protein levels, and were consistent with an 
enhanced constitutive activity of VEGFR2 (Fig. 1G, Online Supp. Fig. 2).  
 
It was possible that these findings could result from increased levels of NOTCH1 ligands or elevated 
Notch1 expression. This second scenario, however, was unlikely since the expression levels of notch1 
and its ligands jagg1, dll1 and dll4 were not increased in PGC-1-/- retinas; indeed, dll4 expression 
was decreased. Furthermore, the elevated level of NICD was not associated with an increased 
expression of the NICD target genes hes1 and hey1, which were comparable between wild-type and 
PGC-1-/- mice, possibly suggesting a reduced transcriptional activity of NICD in PGC-1-/- mice 
(Fig. 1G, Online Supp. Fig. 2). Taken together, these observations suggested that the reduced vascular 
density observed in PGC-1-/- mice did not result from changes in VEGF-A or NICD. 
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To evaluate the role of PGC-1 in the control of angiogenesis in vivo, in a system where VEGF-A 
could be provided in a controlled manner, we used a Matrigel plug assay of neovessel formation and 
injected this matrix subcutaneously into wild-type and PGC-1-/- mice. Three conditions were tested: 
Matrigel rich in growth factors including VEGF, and GFR Matrigel with or without added VEGF. 
Angiogenesis was allowed to proceed for 2 weeks and plugs were extracted and analyzed to evaluate 
the number, size and shape of neovessels. No differences were detected in the number of neovessels 
between wild-type and PGC-1-/- mice (SMA staining; data not shown). In contrast, significantly 
larger blood vessels were detected in PGC-1-/- mice under all conditions tested (Fig. 2A and Online 
Supp. Fig. 3). Furthermore, the shape of the vessels was more irregular in PGC-1-/- animals, with 
larger differences in the axis ratio, and reduced circularity and larger vessel abnormality values (Fig. 
2A). The nature of the vessels was confirmed by staining with the endothelial markers CD31 and 
IsoB4 (Fig. 2B-D). Pericyte coverage, determined by NG2 staining, was also more irregular in PGC-
1-/- mice (Fig, 2C). Figure 2D contrasts a typical branching wild-type vessel on the top panel, with 
examples of the anomalies that we could find in PGC-1-/- mice, from top to bottom we can see, the 
irregularity of the lumen in a lengthwise section of a vessel, with a constriction point, a cross section 
of a collapsed vessel, and a dilated irregular vessel in cross section. 
 
To further evaluate the role played by PGC-1 in the control of vascular stability and the response to 
VEGF-A, we used the oxygen induced retinopathy model (OIR) where one-week-old mice and their 
mothers are first exposed to hyperoxia (75% O2) for 5 days, and then returned to normoxic conditions 
for a further 5 days. This generates a hypoxia inducible factor-1 (HIF-1)-dependent overproduction 
of VEGF-A in the developing retinal vasculature, which promotes neovascularization in the retinal 
periphery. As such, this model recapitulates the vascular anomalies found in proliferative diabetic 
retinopathy [17].  
 
Flat-mount retinas from 17-day-old OIR wild-type and PGC-1-/- mice were immunostained with 
isolectin B4, NG2 and SMA antibodies and examined by confocal microscopy. OIR decreased the 
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general vascular density both in wild-type and PGC-1-/- mice (Fig. 3A, top panel, Online Supp. Fig. 
4). OIR resulted in the loss of pericyte coverage and this reduction was more dramatic in PGC-1-/- 
retinas (Fig. 3A). SMA staining was also more reduced by OIR in PGC-1-/- than in wild-type retinas, 
suggesting that vascular instability induced by the loss of PGC-1 extended also to the 
macrovasculature (Fig. 3A, top panel). Closer examination of isolectin B4-stained vascular structures 
revealed that, compared with wild-type, PGC-1-/- retinas contained highly-disorganized areas (Fig. 
3A, mid panel). High-contrast imaging indicated that pericyte coverage in OIR wild-type animals was 
low but structurally organized (Fig. 3A, mid panel). In contrast, OIR PGC-1-/- mice exhibited an 
aberrant distribution of pericytes with large neovascular structures showing NG2 and SMA staining. 
Quantitative analysis showed reduced lacunarity in the primary plexus and increased junction density, 
in the absence of significant changes in the average vessel length, in OIR PGC-1-/- retinas, (Fig. 3A, 
mid panel). Additionally, a significant increase in the standard deviation (SD) of the junction density 
was detected in OIR PGC-1-/- mice, indicating a more marked disorganization of the retinal plexus. 
Analysis of z-stack layers of high-resolution images allowed the identification of tip cells. In wild-type 
retinas tip cells were typically found in pairs, with filopodia pointing towards each other, and with 
both cells located in the same vascular plexus, whereas tip cells showed no apparent directionality in 
PGC-1-/- retinas (Fig. 3A, bottom panel). 
 
Endothelial intercellular junctions were evaluated by VE-cadherin staining. In wild-type retinas 
normal, membrane bound, staining was preserved while PGC-1-/- mice exhibited diffuse (cytosolic) 
VE-cadherin staining in both capillaries and larger blood vessels (Fig. 5B, left panel, Online Supp. 
Fig. 5). This finding suggested a predominantly intracellular location of VE-cadherin in PGC-1-/- 
mice, with massive loss of intercellular junctions and vascular instability.  
 
As previously reported, OIR in wild-type mice induces the formation of penetrating capillaries across 
the plexiform layer and ECs tufts on the inner limiting membrane of the retina extending into the 
vitreous, which together contribute to the neovascularization process [11]. Using H&E staining to 
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survey the vascular architecture after OIR, anomalous blood vessel formation was also detected in 
PGC-1-/- mice (Fig. 3B, right panel). Indeed, no substantial differences were found between wild-
type and knockout mice in the number of tufts (Online Supp. Fig. 6). However, notable differences 
were found in the ganglionar and inner plexiform layers. PGC-1-/- mice responded to the OIR 
protocol with a more dramatic increase in the number of anomalous blood vessels than wild-type mice 
(Fig. 3B, right panel). Moreover, the vessels in the ganglionar layer were larger in PGC-1-/- mice 
(Fig. 3B, right panel), and, on occasion, hemorrhagic (Online Supp. Fig. 7). All these observations are 
consistent with the results shown in Fig. 2 indicating that the loss of PGC-1 has a particular high 
impact on the structure of the newly formed vessels, rather than on the vessel number. 
 
To evaluate the functional relevance of these findings, we analyzed vascular perfusion and 
permeability by tail vein injection of FITC-dextran. A reduced vascular perfusion together with the 
appearance of hemorrhagic lesions was observed in wild-type mice (Fig. 3C), as previously described 
for OIR. PGC-1-/- mice exhibited a more severe phenotype with extended non-perfused areas 
together with a greater number of larger hemorrhages (Fig. 3C). The three images of Fig. 3C show 
from top to bottom, the whole retina, where we can appreciate the elevated number of hemorrhages in 
PGC-1-/- mice, a higher amplification image, focused on the size comparison between hemorrhagic 
lesion in wild-type and PGC-1-/- mice and a further zoom in image to visualize the absence of 
perfused vessels in extensive areas of PGC-1-/- mouse retinas. The graph at the bottom shows the 
quantification of the number and the size of the hemorrhages. 
 
To investigate whether these anomalies might be related to alterations in the induction of angiogenesis 
mediators, we measured HIF-1, VEGF-A and its downstream effectors in retinas. As expected, OIR 
increased the levels of HIF-1 and VEGF-A protein, increased the phosphorylation of VEGFR2 and 
AKT, and also increased the levels of NICD in wild-type mice (Fig. 3D, top panel). In PGC-1-/- mice, 
OIR resulted in a more marked induction of HIF-1 and a significantly attenuated increase in 
phosphorylated VEGFR2, phosphorylated AKT and NICD (Fig. 3D, top panel), while VEGF-A was 
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induced to the same extent in wild-type and PGC-1-/- retinas. These results suggested that HIF- 
induction is boosted in PGC-1-/- mice, possibly indicating that PGC-1 is working as a negative 
regulator of HIF- protein levels. In fact, HIF-1 is positively regulated by ROS and ROS are 
elevated in the absence of PGC-1. They also indicate that HIF-1 can induce VEGF-A levels both in 
the presence and in the absence of PGC-1. However, while the wild-type mice respond to elevated 
levels of VEGF-A induced by OIR with an corresponding activation of the VEGFR2 and its 
downstream effectors, this activation is significantly blunted in PGC-1 mice, suggesting a poorer 
response to VEGF-A. Retinal mRNA expression levels of the NOTCH1 ligands jagged1, dll4 and 
dll1, of notch1 itself, its target genes hes1 and hey1, vegf-a, flk1 and cdh5 were also evaluated. No 
significant differences were found between wild-type and PGC-1-/- mice, suggesting that the 
phenotype observed was not likely to be attributable to differences in NOTCH1 activity (Fig. 3D, 
bottom panel). Collectively, these results suggest that PGC-1-deficient mice are more sensitive to 
OIR, likely due to an inability to form stable/mature blood vessels. 
 
PGC-1-/- MLECs migrate faster than wild-type cells due to an overproduction of ROS [9]. Indeed, 
ROS are important players in EC migration and proliferation [18], [19]. Thus, we evaluated whether 
the vascular instability in PGC-1-/- mice could be attributed to an excess of ROS. To test this idea, the 
antioxidant EUK-189 was administered to OIR PGC-1-/- mice daily by intraperitoneal injection from 
day 4 to day 7, when the pups entered the hyperoxia chamber, and from day 12 to day 17 when they 
were returned to normoxia. Flat-mount retinas from 17-day-old OIR-treated PGC-1-/- mice were 
immunostained with isolectin B4, NG2 and SMA antibodies. Endothelial staining with isolectin 
showed that EUK-189 did not alter the vascular density of OIR-treated PGC-1-/- mice but improved 
the structural organization of the vascular plexus (Fig. 4A). NG2 staining indicated an improvement in 
coverage in EUK-189-treated mice (Fig. 4A). SMA staining was marginally enhanced by EUK-189, 
although differences were not significant (Fig. 4A). Structural analysis revealed that EUK-189 
treatment increased the average lacunarity in the inner plexus and decreased the junction density, as 
well as its variability, in the primary plexus without significantly changing the total vessel length (Fig. 
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4B). Nevertheless, EUK-189 failed to fully restore the microvascular structure in OIR-treated PGC-
1-/- mice and a significant number of abnormally twisted capillaries were apparent (Fig. 4B). The 
number of tip cells was reduced in EUK-189-treated mice and the tip cells showed a reduced number 
of filopodia but did not show the polarity normally found in tip cells where filopodia can be found 
only on one side of the cell while the other is firmly associated with a stalk cell (Online Supp. Fig. 8). 
The effect of EUK-189 on the vascular anomalies induced by OIR was further analyzed by H&E 
staining of retinal cross-sections. The size of the abnormal blood vessels in the ganglion cell layer and 
the inner plexiform layer was reduced by EUK-189 treatment (Fig. 4C). These observations suggested 
that the reduced vascular stability provoked by the absence of PGC-1 was partially restored by 
antioxidant treatment. 
 
Finally, to test whether this structural recovery was associated with a restoration of a normal VEGF-A-
dependent response, we measured protein (Fig. 4D) and mRNA levels (Online Supp. Fig. 9) of VEGF-
responsive factors. EUK-189 treatment significantly reduced the levels of HIF-1, phosphorylated 
VEGFR2, and NICD, but had no effect on VEGF-A protein levels, suggesting that in vivo treatment 
with EUK-189 improved VEGF-A signaling in PGC-1-/- mice. EUK-189 treatment did not produce 
significant changes in the mRNA levels of notch1, its ligands dll1, dll4, its targets hes1, hey1, or flk1 
and cdh5, indicating that EUK-189 did not modulate NOTCH1 activity. 
 
Discussion 
 
The present study shows that PGC-1 plays an important role in the control of angiogenesis and in the 
stability of the mature vasculature. In the absence of PGC-1, the vascular endothelium appears to be 
constitutively activated, probably due to elevated ROS levels that cause constitutive activation of the 
VEGF-A signaling pathway. These alterations are likely to be relevant in diabetic retinopathy where 
PGC-1 activity is generally found to be low. 
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The physiological consequences of PGC-1 deficiency in angiogenesis were analyzed in the retinas of 
PGC-1-/- mice. The retinal vasculature showed clear signs of instability, including a reduction in 
endothelial intercellular junctions and a significant loss of pericyte coverage. Furthermore, tip cells 
could be found in what should be quiescent vessels and displayed a lack of polarity. Reduced pericyte 
coverage is unlikely to be the result of defective recruitment but rather to their ulterior loss since 
pericytes were found in regions of active angiogenic activity. These alterations closely resemble those 
observed in diabetic retinopathy, however, VEGF-A protein levels were comparable in retinas from 
both groups of mice suggesting that differences in VEGF-A levels were not responsible for the 
observed phenotype. 
 
Since elevated VEGF-A levels are generally regarded to be the main driver of the formation of 
anomalous blood vessels in diabetic retinopathy [20], we used the OIR protocol that recapitulates most 
if not all features of human diabetic retinopathy to question how PGC-1-deficient mice respond to 
VEGF-A. OIR exacerbated the vascular instability observed under basal conditions in PGC-1-/- mice. 
The number of anomalous blood vessels was unaffected by the loss of PGC-1, but these vessels were 
larger, fully collapsed and/or largely irregular in diameter. Analysis of the VEGF-A signaling pathway 
suggested that in wild-type animals OIR induces an activation of the pathway while in PGC-1-/- 
animals the pathway is constitutively active and is nonresponsive to elevated VEGF-A levels. 
Importantly, HIF-1 levels are more strongly induced in PGC-1-/- deficient mice and could account 
for the exacerbation of the phenotype. 
 
PGC-1-deficient ECs have elevated levels of ROS [7] and antioxidant treatment reestablishes the 
normal motility of PGC-1-deficient ECs [9]. Given that the VEGF-A signaling pathway has been 
shown to be ROS sensitive [21,18,22], we hypothesized that elevated ROS could be responsible for 
the observed phenotype. Consistent with this hypothesis, antioxidant treatment partially restored 
vascular structure and VEGF-A signaling in PGC-1-deficient mice.  
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It is generally acknowledged that pericyte coverage is essential for vessel stabilization and 
there are several pathways involved in the intimate crosstalk between the vascular endothelial 
cell and the pericyte. As a result, endothelial dysfunction generally results in pericyte loss and 
vice versa. Among the pathways involved, the TGF-, and the angiotensin system have been 
extensively characterized [23]. Importantly, the VEGFR2 has also been shown to be involved 
in this regulatory process [24]. In light of the previous evidence showing that loss of PGC-1 
results in enhanced cell migration and of the present results suggesting that loss of PGC-1 
alters the VEGFR2 signaling pathway, it is possible that this alteration may be responsible for 
the observed loss in pericyte coverage, although alternative scenarios are also possible. 
Importantly, recent reports suggest a connection between the TGF- pathway and PGC-1 
[25]. 
 
That antioxidant treatment was not sufficient for a complete functional recovery in OIR-treated PGC-
1-/- retina raises several questions. It could be considered that since ROS are part of the normal 
signaling processes, complete detoxification of ROS cannot be expected to be fully beneficial [26]. 
Another reasonable possibility is that part of this phenotype cannot be attributed to ROS alone, and 
might involve other PGC-1 target genes.  
 
An attractive hypothesis is that PGC-1 might be necessary to recover the endothelial oxidative 
capacity following the “ischemic” period. In the OIR model, hyperoxia produces vasoconstriction that 
results in tissue hypoxia, activation of HIF-1, and HIF-1-dependent induction of VEGF-A [27]. 
HIF-1 activates glycolytic metabolism to prevent cell death during hypoxia [28]; however, excessive 
HIF-1 activity prevents the re-activation of oxidative metabolism and stabilization of the newly-
formed vasculature by an unknown mechanism. This inability to perfuse results in organ damage e.g. 
cardiac hypertrophy [29]. Therefore, it is possible that the exacerbation of the vascular anomalies 
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observed in OIR-treated animals and the partial effect of antioxidants can be attributed to the inability 
of ECs to reinitiate oxidative metabolism following HIF-1 activation, in the absence of PGC-1.  
 
In conclusion, our study supports the idea that PGC-1 plays a major role in the control of 
angiogenesis and is likely to be relevant in diabetic retinopathy. Furthermore, it suggests that 
constitutive activation of the VEGF-A signaling pathway can limit the therapeutic potential of VEGF-
A-based therapies in the absence of a good redox balance. Future studies should be directed to 
investigate this re-wiring of normal ROS homeostasis. 
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Figure Captions 
 
Fig. 1 Reduced pericyte coverage, structural disorganization, and impaired perfusion in retinas from 
PGC-1-/- mice despite normal VEGF-A levels. a) Flat-mount retinas from wild-type and PGC-1-/- 
mice were immunostained with Isolectin B4 (ECs), NG2 (perycites), SMA (smooth muscle) and VE-
cadherin (EC tight junctions). a-top) Center to edge sections show general vascular system (10X 
objective). a-mid) Arterioles and microvasculature (40X objective). a-bottom) Tip cells (60X 
objective). b-top) VE-cadherin staining in the microvasculature (40X objective). b-bottom) H&E 
staining of retina cross sections from wild-type and PGC-1-/- mice. c) Flat-mount retinas from wild-
type and PGC-1-/- mice perfused with FITC dextran; the lower panel shows higher magnification 
images. d) Western blot analysis of retinal extracts of relevant proteins in the control of angiogenesis: 
VEGF-A, VEGFR2, NICD and AKT. Data are from 3 independent experiments, n=3-5 animals per 
group in each independent experiment. Data are mean±SD. * p ≤ 0.05 vs. control. 
 
Fig. 2 Absence of PGC-1 results in the formation of enlarged and irregular blood vessels in Matrigel 
implants. a-d) Immunofluorescence stain of Matrigel implants from wild-type and PGC-1-/- mice. a) 
SMA stain of Matrigel implants, and GFR Matrigel implants with or without VEGF-A (25X 
objective). b) CD31 and DAPI (40X objective c) CD31, NG2, DAPI (60X objective).). d) IsoB4, 
NG2, SMA, DAPI (40X objective). Data are from 3 independent experiments, n=3-5 animals per 
group in each independent experiment. Data are mean±SD. * p ≤ 0.05 vs. control. 
 
Fig. 3 OIR in PGC-1-/- mice severely disrupts the retinal vascular structure, but does not induce 
VEGF-A levels or activity. Abnormally large blood vessels in the ganglionar layer, loss of endothelial 
junctions, highly irregular vascular plexus with poor pericyte coverage, and large hemorrhagic areas 
are observed in PGC-1-/- mice. a) Flat-mount retinas from wild-type and PGC-1-/- mice where 
immunostained with Isolectin B4, NG2, SMA, and VE-cadherin. a-top) Center to edge sections show 
general vascular system (10X objective). a-mid) Arterioles and microvasculature (40X objective). a-
GARCÍA-QUINTANS ET AL. 
25  
bottom) Tip cells (60X objective). b-left) VE-cadherin stain in the microvasculature (40X objective). 
b-right) H&E stain of retina cross-sections from wild-type and PGC-1-/- mice. c) Flat-mount retinas 
from wild-type and PGC-1-/- mice perfused with FITC dextran; lower panels show higher 
magnification images. d-top) Western blot analysis of retinal extracts of relevant proteins in the 
control of angiogenesis: VEGF-A, VEGFR2, NICD and AKT. d-bottom) qRT-PCR analysis of 
mRNA levels of relevant genes in the control of angiogenesis. Data are from 3 independent 
experiments, n=3-5 animals per group in each independent experiment. Data are means ±SD. * p ≤ 
0.05 vs. control. 
 
Fig. 4 Severity of OIR in PGC-1-/- mice is prevented by EUK-189 treatment. a-c) Flat mount retinas 
from wild-type and PGC-1-/- mice were immunostained with Isolectin B4 (endothelial cells), NG2 
(pericytes), SMA (smooth muscle cells) and VE-cadherin (tight junctions of ECs). a) Center to edge 
sections of the vascular system (10X objective). b) Arterioles and microvasculature (40X objective). 
c) H&E stain of retina cross-sections from wild-type and PGC-1-/- mice. d) Western blot analysis of 
retinal extracts of relevant proteins in the control of angiogenesis. Data are from 3 independent 
experiments, n=3-5 animals per group in each independent experiment. Data are means ±SD. * p ≤ 
0.05 vs. control. ns = not significant. 
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Point by point answer to reviewers: 
 
Reviewer 1: 
 
1. The language can be tightened up in several places: examples are in abstract 
line 2: "—has been show to be—" should be "has been shown to be—" and in 
introduction,  and page 5, paragraph 2, line 2 should be "---mitochondrial function and 
ROS—" Also in results page 11, paragraph 2, "—matrigel plugs where used—" should 
be "—plugs were used---"  
 
Answer. The text has been revised and corrected as indicated. 
 
2. Abstract: Line 4: It is more appropriate to refer this study as aiming to study 
the development of oxygen-induced retinopathy. Although they share some features, the 
model they used is oxygen-induced and not diabetes induced retinopathy.  
 
Answer. The sentence has been corrected and now reads: “This study aimed to 
investigate the contribution of PGC-1 inactivation to the development of oxygen-
induced retinopathy.” 
 
3. The conclusion at the end of abstract also refers to the role of mitochondrial 
ROS in the vascular abnormalities in PGC-1a deficient mice; this is based on partial 
reversal by an anti-oxidant. This conclusion is overstated. It is not clear that EUK-189 
specifically scavenges mitochondrial ROS. It is more appropriate to say a role for ROS 
is possible based on partial reversal by EUK-189  
 
Answer. The sentence has been corrected and now reads: “This phenotype could be 
partially reversed by antioxidant administration, indicating that elevated production of 
ROS in the absence of PGC-1 could be a relevant factor in the alteration of the VEGF-
A signaling pathway.” 
 
4. Methods section, it is important to mention what conc. of O2 and for how 
many days the pups were exposed for the retinopathy model in mice. This is particularly 
Response to reviewers with figures Click here to download Attachment to manuscript Response to
reviewers with figures.doc
Click here to view linked References
important to evaluate the effects of EUK compound and how its timing of administration 
corresponds to O2 exposure.  
 
Answer. The required details have now been included in the Methods section. The text 
now reads: “In brief, p7 pups where transferred with their mothers to a hyperoxia 
chamber set at 70% O2 where they stayed for 5 days, and then returned to normoxic 
conditions. P17 pups were sacrificed. EUK-189 (30 mg/kg in PBS) was administered 
daily by intraperitoneal injection from day 4 to day 7 and from day 12 to day 17.” 
 
5. The specific anti-oxidant properties of EUK-189 need to be mentioned- does it 
scavenge superoxide or H2O2? If so it is limited to cytosolic compartment or does it get 
targeted to mitochondria?  
 
Answer. The required details and references have now been included in the Methods 
section. The following sentence has been included in the text: “EUK-189 is a salen-
manganese complex and superoxide dismutase/catalase mimetic that has been shown to 
be effective as antioxidant in vivo and in the inactivation of mitochondrial ROS [12].” 
 
6. The manuscript refers to increase in mitochondrial ROS as possible 
mechanism involved in PGC-1α deficient mice; however the study did not attempt to 
measure even qualitatively differences in mitochondrial ROS between WT and PGC-1α 
deficient mice  
 
Answer. Elevated ROS in PGC-1-/- cells (vascular endothelium, MEFs, primary 
hepatocytes) have been reported (Y. Olmos et al., JBC, 2009; S. Borniquel et al., MCB, 
2010; C. Sánchez-Ramos et al., ARS, 2011) elevated levels of ROS induced 
modifications (protein carbonylation) in PGC-1-/- mice have been reported (F. Derbré 
et al., AGE, 2011). 
 
 
Mouse Lung Endothelial Cells (MLEC) 
S. Borniquel et al., MCB, 2010 
 
 
 We have now analyzed the level of oxidative protein modification in wild-type and 
PGC-1-/- MLEC, the results are shown in Supp. Fig. 11. 
 
7. The loss of mitochondria and oxidative capacity has been speculated in the 
PGC-1α deficient mice as potential mechanisms involved in the disorganized 
microvasculature. However, it is unclear whether mitochondrial biogenesis is disrupted 
in the vessels. It is possible that loss of PGC-1α leads to defective angiogenesis through 
other mechanisms.   
 
Answer. We have now evaluated mitochondrial density and cellular distribution (a 
hallmark of mitochondrial activity) in wild-type and PGC-1-/- primary endothelial 
cells. We have found a reduced mitochondrial density and a more pronounced 
perinuclear distribution in PGC-1-/- cells, supporting the hypothesis of a disrupted 
mitochondrial biogenesis and reduced mitochondrial activity. Results are shown in 
Supp. Fig. 10. 
 
8. Loss of pericyte coverage is an important observation. The potential 
mechanisms are not addressed further in the study protocol or in the discussion.  
 
Answer. We have now discussed this important issue in the Discussion section. The 
added text reads: “It is generally acknowledged that pericyte coverage is essential for 
vessel stabilization and there are several pathways involved in the intimate crosstalk 
between the vascular endothelial cell and the pericyte. As a result, endothelial 
dysfunction generally results in pericyte loss and vice versa. Among the pathways 
involved the TGF-, and the angiotensin system, have been extensively characterized. 
Importantly, the VEGFR2 has also been shown to be involved in this regulatory 
process. In light of the previous evidence showing that loss of PGC-1 results in 
enhanced cell migration and of the present results suggesting that loss of PGC-1 alters 
the VEGFR2 signaling pathway, it is possible that this alteration may be responsible for 
the observed loss in pericyte coverage, although alternative scenarios are also possible. 
Importantly, recent reports suggest a connection between the TGF- pathway and PGC-
1.”  
 9. Results: Figure 1, Panel B summary graph for VCadherin shows similar 
fractions of membrane bound and cytosolic staining, however in the results section, 
authors state that VCadherin staining is more cytosolic and less membrane bound in 
PGC-1a -/- mice. This requires clarification.  
 
Answer. The text read: “Although VE-cadherin staining was reduced in PGC-1-/- animals, 
normal membrane distribution was preserved”. It meant to explain that the total signal (protein 
amount) for VE-cadherin was reduced in PGC-1-/- animals but that the distribution of the 
signal was not different in WT versus KO animals, and that is what is shown in the graph. To 
avoid misunderstandings we have changed the text that now reads: “VE-cadherin staining 
showed that its normal membrane distribution was preserved in PGC-1-/- animals”. 
 
10. Figure 1, Panel D, representative blot appears to show higher intensity band for 
VEGFA in the -/- mice, however, the summary graph shows no difference. Considering the HIF-
1 activation in -/- mice, one would expect higher VEGFA. This needs clarification.  
 
Answer. The blots show exactly what we got, the protein levels of VEGF-A where if anything 
higher in PGC-1-/- animals, but the differences did not reach statistical significance. That 
VEGF-A levels are not significantly elevated may be due to the described induction of VEGF-A 
expression by PGC-1, in fact VEGF-A mRNA levels are reduced in the PGC-1-/- mice. This 
information is included in the text and shown in Supp. Fig. 2. 
 
11. The legend for Figure 2 has transposed description of panel D for panel B. This 
makes the figure confusing to interpret. Also more detailed description of findings is needed for 
this complex figure. Panel D alone has multiple photo-micrographs that need explanation for 
the reader  
 
Answer. The transposition has been fixed. We have also expanded the discription of 
Figure 2D, that now reads: Fig 2D contrasts a typical branching wild-type vessel on the top 
panel, with examples of the anomalies that we could find in PGC-1-/- mice, from top to bottom 
we can see, the irregularity of the lumen in a lengthwise section of a vessel, with a constriction 
point, a cross section of a collapsed vessel, and a dilated irregular vessel in cross section. 
 
12. Figure 3 also has extensive data with scant description of the panels and 
interpretation of data. The figure can be split into 2 and better explanation given to be 
able to assess the changes with O2 exposure.  
 
Answer. We have now expanded the description and interpretation of Figure 3 as 
suggested. 
 
13. The authors discuss the possibility that ischemia leads to loss of PGC-1a, which then 
leads to activation of HIF-1a signaling. This possibility can be tested by blotting for PGC-1a in 
the retina in the WT mice in control and OIR stress. Along the same lines, a blot to show that 
PGC-1a is indeed lost in the -/- animals is needed to verify the KO 
 
Answer. We have studied the regulation of PGC-1 by hypoxia in the context of 
another study that we are about to submit for publication (C. Sanchez et al.). We 
confidentially include here some of the data that shows that PGC-1 is downregulated 
by hypoxia (1% O2) when cells are cultured in vitro at physiological O2 concentrations 
(3% O2), and induced by reoxigenation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
We have included a western blot for PGC-1 in Supp. Fig. 11. 
